Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis

PURPOSE: Netarsudil is a Rho kinase inhibitor and the first new class of clinically useful ocular hypotensive agents. In this study, we conducted a systematic literature review and meta-analysis to summarize and synthesize the available evidence on the efficacy and safety of fixed-dose combination (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong-Wook, Ahn, Hyeon-Soo, Chang, Jinho, Kang, Hye-Young, Chang, Dong-Jin, Suh, Jae Kyung, Lee, Hankil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Ophthalmological Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582491/
https://www.ncbi.nlm.nih.gov/pubmed/35989070
http://dx.doi.org/10.3341/kjo.2022.0061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582491/
https://www.ncbi.nlm.nih.gov/pubmed/35989070
http://dx.doi.org/10.3341/kjo.2022.0061

Ejemplares similares